▶️Nov 6, 2022
Eric Topol
The1st study to show improvement in long-term outcomes after Paxlovid—including less #LongCovid, deaths, hospitalizations & complications—is a major advance. I've reviewed it: https://erictopol.substack.com/p/paxlovid-and-long-covid
Paxlovid and Long Covid

A new study sheds light on a bonus benefit after the acute phase

Ground Truths
Nov 6, 2022 at 6:18pmWeb
Show threadKumachanNov 6, 2022
@erictopol I am alltimes a bit surprised for your actual expertise,because I well remember your presenting Alteplase in the 80s in Santiago de Compostela,therefore your name is always connected with my great respect for your using thrombolysis in myocardial infarction so soon in ambulance,really remarkable.
I have been a very beginning medical reporter that time sent from Vienna.
Show thread@dickretiredNov 6, 2022
@erictopol
What about Evoshield. Any good evidence there?
Show threadkriztenNov 9, 2022
@dickretired @erictopol great point! Friends have done well when given it! Hell, bebtelovimab helped me for awhile after last infection!
Show threadM MorganNov 6, 2022
@erictopol Would like to know the rate of #LongCOVID for those that have rebound infections. (It is high anecdotally)
Show threadDrMikeStantonNov 6, 2022
@erictopol definitely seems worth the 2nd look even despite reports of rebound infections.
Show threadKarl Schwartz, Artist advocateNov 6, 2022
@erictopol